Search results
'Lost his mind': Defense attorney claims insanity for man accused of killing UA professor
AZCentral | The Arizona Republic via Yahoo News· 6 days agoAn attorney for the man accused of fatally shooting Thomas Meixner on the University of Arizona campus in 2022 wants his client to be found guilty except insane.
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 6 days ago...to severely active ulcerative colitisa (UC) receiving subcutaneous (SC) TREMFYA® (guselkumab) 200 mg every four weeks (q4w) and 45.2 percent (p<0.001) of patients receiving SC TREMFYA® 100 mg every eight weeks (q8w) achieved the primary endpoint of clinical remissionb at Week 44 compared to...
Nice start to the holiday weekend in New Hampshire before rain moves in Monday
WMUR New Hampshire· 1 day agoA nice holiday weekend is ahead in New Hampshire, but some rain will move in Monday.
ADHD affects 1 in 9 kids in US, new report reveals: ‘Shame and stigma’
Fox News· 2 days agoDiagnoses of ADHD continue to rise among U.S. youth, affecting one in every nine U.S. kids....
...Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO)...
Digital Journal· 3 days agoOral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task forceTop line results imminent ...
Scientists sound alarm over drinking tap water when pregnant
Newsweek· 6 days agoScientists have urged expectant mothers to avoid drinking unfiltered tap water after finding a link...
Transitioning gender identities is not linked with depression
Science Daily· 4 days agoThe study followed 366 LGBTQ+ young people ages 15-21 in two U.S. cities from 2011 to 2015 and measured depressive symptoms periodically, as well as the young people's self-reported ...
ADHD diagnoses are rising. 1 in 9 U.S. kids have gotten one, new study finds
KPBS San Diego· 3 days agoAbout 1 in 9 children in the U.S., between the ages of 3 and 17, have been diagnosed with ADHD....
2 Billion More Reasons to Buy AbbVie Stock | The Motley Fool
The Motley Fool· 4 days agoThere are plenty of reasons to buy a leading biopharma business like AbbVie (ABBV -0.85%), and...
Mira Pharmaceuticals Advances Preclinical Trials T | Newswise
Newswise· 6 days agoMIAMI, May 20, 2024 -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic ...